News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
W. Michael Korn: The FDA just granted marketing authorization for the Invitae Common Hereditary Cancers Panel.
Photo from W. Michael Korn/LinkedIn
Oct 2, 2023, 18:25

W. Michael Korn: The FDA just granted marketing authorization for the Invitae Common Hereditary Cancers Panel.

W. Michael Korn, Chief Medical Officer for Oncology at Invitae, shared on LinkedIn:

“The FDA just granted marketing authorization for the Invitae Common Hereditary Cancers Panel. This is a first-in-class authorization for a DNA test capable of assessing predisposition to a multitude of cancer types – a fantastic testament to Invitae’s high-quality testing capabilities and the incredible people at Invitae who made this happen. The FDA decision is a major win for patients, providing access to high-quality testing with broad clinical utility.”

For details click here.
Source: W. Michael Korn/LinkedIn

cancer FDA Hereditary Cancers Invitae OncoDaily Oncology W. Michael Korn
Special Coverage
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system
Blog
Nov 13, 2024, 09:55
Moderna Incorporation announced the awardees of its 2024 Australia Fellowship Program
Blog
Nov 13, 2024, 09:39
AI tools to improve diagnosis and therapy in neuro-oncology
Insight
Nov 13, 2024, 09:27
Nikki Rossetti et al. on Early-Stage Lung Cancer in the Era of Lung Cancer Screening
Blog
Nov 13, 2024, 09:14
Yüksel Ürün: Key takeaways on high-risk and locally advanced prostate cancer from António Rui Azevedo Freitas
Blog
Nov 13, 2024, 09:11
Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy
Blog
Nov 13, 2024, 09:09
Yüksel Ürün: Not all that shines is Prostate cancer – a striking reminder from Daniela Oprea-Lager
Blog
Nov 13, 2024, 09:01
Updated Results with Mitazalimab as a first-line treatment for advance pancreatic cancer
Blog
Nov 13, 2024, 08:59
Miriam Mutebi: What To Expect During A Mammogram
Insight
Nov 13, 2024, 08:56
Rachel Riechelmann: Low dose Everolimus for patients with Neuroendocrine tumors
Insight
Nov 13, 2024, 08:51
Reporting pharmacogenetic variants and cancer WGS data could guide safer prescribing